GB2081580A - Sapindus trifoliatus extracts - Google Patents

Sapindus trifoliatus extracts Download PDF

Info

Publication number
GB2081580A
GB2081580A GB8025840A GB8025840A GB2081580A GB 2081580 A GB2081580 A GB 2081580A GB 8025840 A GB8025840 A GB 8025840A GB 8025840 A GB8025840 A GB 8025840A GB 2081580 A GB2081580 A GB 2081580A
Authority
GB
United Kingdom
Prior art keywords
pericarp
extract
fruit
medicament
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB8025840A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB8025840A priority Critical patent/GB2081580A/en
Publication of GB2081580A publication Critical patent/GB2081580A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/77Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

A topical medicament for the promotion of hair growth comprises an extract from the pericarp of the fruit of Sapindus trifoliatus L. This extract is obtained by air-drying the pericarp of the fruit of Sapindus trifoliatus L., grinding the dried pericarp and soaking the ground pericarp in a polar solvent such as 70% aqueous propan-2-ol and fitering the resulting solution. The extract has been found to contain galactose, fructose, oleic palmitic, linolenic and stearic acids; stigmasterol, beta -sitosterol, camposterol and cholesterol.

Description

SPECIFICATION A medicament for the promotion of hair growth and a process for preparing same The present invention relates to a topical medicament which maybe used to alleviate the problems of hair loss, dandruff and associated skin diseases.
According to the present invention there is provided a topical medicament for the promotion of hair growth and alleviation of dandruff comprising an extract from the pericarp of the fruit of Sapindus trifoliatus L.
Preferably the extract comprises a polar solvent soluble fraction containing galactose, fructose, oleic, palmitic, linolenic and stearic acids, stigmasterol, psitosterol, camposterol and cholesterol.
Advantageously the polar solvent is 70% aqueous propan-2-ol.
A process for preparing the medicament according to the invention comprises air-drying the pericarp of the fruit of Sapindus trifoliatus L., grinding the dried pericarp, soaking the ground pericarp in a polar solvent to form a solution of extract in solvent and filtering the solution.
Preferably the filtrate is stored in the dark until use.
Preferably the dried pericarp is soaked for a period of 24 hours in 70% aqueous propan-2-ol.
A series of tests were carried out on severe dandruff and excessive hair loss sufferers by ten trichologists in England and Scotland.
Medicaments made up of extracts from Sapindus trifoliatus L. were provided in 100 ml nozzled P.V.C.
bottles for direct application, twice daily, to the hair partings on the scalp. No prenor post-application hair wash or massages were carried out.
The extracts were obtained from the fruit of Sapindus trffollatus L. by air drying of the pericarp of the fruit, grinding the dried pericarp and soaking the ground pericarp for 24 hours in 70% propan-2-ol.
The resulting solution was then filtered and the filtrate was stored in the dark prior to use.
Table 1 below illustrates the results of the tests on 70 volunteers, all of whom were suffering from severe dandruff with or without excessive hair loss.
Male and female patients with Pityriasis Simplex (A), Pityriasis Steatoides (B) and Seborrhoeic Dermititis (C) were included. In view of the fact that the medicament has a drying effect on the scalp, patients with Pityriasis Sicca were excluded.
An ancillary double-blind test using 20 volunteers indicated that 20% noted an improvement in dandruff symptoms with the placebo of solvent only (70% propan-2-ol).
Responses were graded according to the following key.
Grading of Dandruff Lesion Pityriasis Simplex -A Pityriasis Steatoides - B Seborrhoeic Dermatitis - C Grading of Response at the end of 4 weeks Dandruff - Worse O No effect + Patient notes improvement, but not observer ++ Slight improvement +++ Significant improvement ++++ Eliminated HafrLoss - Worse O No effect + Doubtful improvement ++ Slight improvement +++ Significant improvement ++++ Hair loss normalized Table 1.
No. of Duration Dandruff Excessive hair loss volunteers Age Sex (years) Type Result Duration Result 1 36 M 10 B ++++ 1 ++++ 2 49 M 13 C ++++ 0.5 +++ 3 41 M 11 B +++ 4 4 27 M 5 C ++ 5 5 47 M 15 C ++ 6 53 M 15 B + 7 34 F 10 C ++++ 8 42 F 12 C ++++ 2 ++++ 9 47 M 5 B ++++ 1 ++++ 10 29 M 2 C ++++ 11 40 M 4 C ++++ 12 22 M 7 C ++++ 13 39 M 3 B ++++ 14 38 M 2 C ++++ 15 20 M 2 B ++++ 16 23 F 4 C ++++ Table 1 contd.
17 75 F 10 C +++ 18 27 M 8 C ++++ 19 22 M 4 C ++ 20 60 F 10 C ++ 5 ++++ 21 29 M 2 B ++++ 22 48 F 10 C ++++ 2 +++ 23 45 F 6 C ++++ 6 ++++ 24 38 F 8 C ++++ 3 +++ 25 60 F 12 C ++++ 1 ++++ 26 54 M 8 C ++++ 0.5 +++ 27 50 M 10 B ++++ 2 ++++ 28 42 M 4 C +++ 29 18 F 1 B ++++ 2 +++ 30 61 F 10 B + 1 +++ 31 68 F 15 C +++ 32 16 F 1 C ++++ 4 ++++ 33 18 M 2 C +++ 1 +++ 34 25 F 3 B +++ 1 +++ 35 78 F 20 B + 1 0 36 52 F 8 A + 2 0 37 77 F 20 B 0 38 60 F 14 C O 39 33 F 3 A ++++ 40 44 F 6 A +++ 41 38 F 8 A +++ 3 ++++ 42 61 F 10 B O 43 17 F 1 C O 44 16 M 1 B ++++ 45 18 F 2 C ++++ 46 21 F 4 C ++++ 47 23 F 5 C +++ 48 37 F 8 C ++++ 49 77 F 20 C ++++ 4 ++++ 50 66 F 18 C ++++ 2 ++++ 51 73 F 20 C O 52 69 F 25 C ++++ 1 +++ 53 58 F 10 C ++++ 1 +++ 54 58 F 10 C ++++ 1 +++ 55 56 M 15 B ++++ 1 +++ 56 43 M 10 B O 57 41 M 8 C ++++ 58 68 F 20 C +++ 59 42 M 10 C ++ 60 28 M 6 C +++ 4 0 61 34 M 6 C ++ 2 0 62 36 F 4 C ++ 1 0 63 40 F 8 C ++ 2 - 64 32 F 7 C ++ 1 - 65 48 F 8 C +++ 2 +++ 66 60 M 10 A +++ 3 +++ 67 28 M 4 A +++ 1 +++ 68 39 F 5 B +++ 69 42 F 10 B ++ 70 28 M 4 B +++ The results of these preliminary tests suggested a significant improvement in the symptoms of both males and females following treatment for 4 weeks.
These observations provided a basis for investigating the effects of extracts on an experimental animal, the normal, outbred mouse. Abundant hair growth was noted in treated female mice whereas this response was not evident in male animals.
Extracts were prepared as before by soaking ground, air-dried pericarp of Sapindus trifollatus L.
fruit for 24 hours in 70% propan-2-ol; the solution was then filtered and stored in the dark. In all experiments the treatment consisted of daily applications of extract and control solutions to shaved patches of skin chosen symmetrically on either side of the dorsal midline of each mouse. Treatment was continued for periods of from 4 to 5 weeks on animals of known ages. The animals were then killed and samples of the skin from the treated areas were taken for detailed histology. In some instances, the skin samples were sectioned in two directions, parallel and at right angles to the midline. At least 10 sections were picked out at 240 zm intervals from the ribbon of serial sections available for each skin sample.
In one test, 9 animals were treated with the extract and another 9 with solvent only. The two groups were formed by allocating to each an equal number of animals from each one of two litters. In another test 21 animals were treated with extract on one side of the back and with solvent on the other side.
A consistent difference between all treated and control samples was noted when the results were grouped by the sex of the animals. The stage of hair cycle at the start of treatment was not known except that there could be no difference between sibs. At the end of treatment the stage is seen in the histological sections.
In female mice, the samples treated with extract showed abundant hair growth, with hair reaching all through the subcutaneous adipose tissue even where the corresponding solvent-treated animal or solvent-treated side was in the resting stage (telogen) of the hair growth cycle (Dry, 1926) (Fig. 1).
The extract appeared to have a localised influence on the progress of the hair development cycle, and favoured retention of hair in its fully grown ('anagen') stage. Alternatively, the extract may have shortened the telogen stage and thus brought forward the next hair cycle, but this is unlikely in view of the fact that intermediary stages were not evident.
Only further work, involving skin sampling at the start of treatment and at several intervals thereafter could provide a final decision between the two alternatives.
In male animals, on the other hand, there were no significant histological differences between extract and solvent-treated zones.
Related studies were carried out on the chemical composition of the extract and source material.
Samples were derivatised with bis-trimethylsilyl (trifluoro) acetamide and analysed by combined gas chromatography-mass spectrometry (Hillman et al, 1975). Positive identifications were made of galactose and fructose, and the fatty acid oleic, palmitic, linolenic and stearic acids as well as the sterols stigmasterol, sitosterol, campesterol and cholesterol. No other steroids could be detected even when using selective ion detection mass fragmentography (Young etal, 1977).
The differential response noted between female and male mice cannot be attibuted, therefore, to the presence in the extract of significant quantities of steroidal oestrogens, although some plant species are known to synthesis these compounds (Young et al, 1977, 1978) and related substances (Guens, 1978).
None of the compounds indentified in the extract has been reported to modify hair growth and further studies on the active compoments of the extract are merited. Moreover, in contrast to the experiments on mice, there was no evidence from the clinical trials on humans to suggest that hair growth was different in males and females treated with extract. Comparisons between animal experiments and the human are in any case inappropriate because baldness in man is not connected to hair growth cycles.

Claims (6)

1. A topical medicament for the promotion of hair growth and alleviation of dandruff comprising an extract from the pericarp of the fruit of Sapindus trifoliatus L.
2. A medicament according to claim 1 wherein the extract comprises a polar solvent soluble fraction containing galactose, fructose; oleic, palmitic, linolenic and stearic acids; stigmasterol, Rsitosterol, camposterol and cholesterol.
3. A medicament according to claim 1 or claim 2 wherein the solvent is propan-2-ol.
4. A process for preparing the medicament claimed in claim 1 comprising air-drying the pericarp of the fruit of Sapindus trifoliatus L., grinding the dried pericarp soaking the ground pericarp in a polar solvent to form a solution of extract in solvent and filtering the solution.
5. A process according to claim 4 wherein the filtrate is stored in the dark until use.
6. A process according to claim 4 or 5 wherein the dried pericarp is soaked for a period of 24 hours in 70% aqueous propan-2-ol.
GB8025840A 1980-08-07 1980-08-07 Sapindus trifoliatus extracts Withdrawn GB2081580A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8025840A GB2081580A (en) 1980-08-07 1980-08-07 Sapindus trifoliatus extracts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8025840A GB2081580A (en) 1980-08-07 1980-08-07 Sapindus trifoliatus extracts

Publications (1)

Publication Number Publication Date
GB2081580A true GB2081580A (en) 1982-02-24

Family

ID=10515312

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8025840A Withdrawn GB2081580A (en) 1980-08-07 1980-08-07 Sapindus trifoliatus extracts

Country Status (1)

Country Link
GB (1) GB2081580A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6468307A (en) * 1987-09-09 1989-03-14 Maruzen Kasei Co Ltd Hair cosmetic
EP0793489A1 (en) * 1994-09-13 1997-09-10 Ramot University Authority For Applied Research & Industrial Development Ltd. Compositions for the treatment of skin disorders
FR2873024A1 (en) * 2004-07-13 2006-01-20 Oreal Cosmetic treatment, useful e.g. to prevent and/or decrease hair fall or bristle fall, comprises applying a transdermal deliver system to skin/scalp, where the composition of the transdermal system comprises non-essential micronutrient
CN101607145B (en) * 2008-06-18 2012-04-18 许恒瑞 Method for extracting interfacial active sapindoside and organic matter from soapberry fruit and finished product

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6468307A (en) * 1987-09-09 1989-03-14 Maruzen Kasei Co Ltd Hair cosmetic
JP2588723B2 (en) * 1987-09-09 1997-03-12 丸善製薬株式会社 Hair cosmetics
EP0793489A1 (en) * 1994-09-13 1997-09-10 Ramot University Authority For Applied Research & Industrial Development Ltd. Compositions for the treatment of skin disorders
EP0793489A4 (en) * 1994-09-13 2001-12-19 Univ Ramot Compositions for the treatment of skin disorders
FR2873024A1 (en) * 2004-07-13 2006-01-20 Oreal Cosmetic treatment, useful e.g. to prevent and/or decrease hair fall or bristle fall, comprises applying a transdermal deliver system to skin/scalp, where the composition of the transdermal system comprises non-essential micronutrient
CN101607145B (en) * 2008-06-18 2012-04-18 许恒瑞 Method for extracting interfacial active sapindoside and organic matter from soapberry fruit and finished product

Similar Documents

Publication Publication Date Title
Montagna et al. The distribution of glycogen and lipids in human skin
JPH0128726B2 (en)
US2320478A (en) Toilet preparation
DE2963117D1 (en) Ubiquitary tissue protein pp8 and process for its preparation
GB2081580A (en) Sapindus trifoliatus extracts
JPS63283552A (en) Health food mainly containing kind of sweet potato originating from brazil
EP0338459A2 (en) Composition for promoting hair growth in androgenetic alopecia and method thereof
Putra et al. The potency of Hibiscus rosa-sinensis Linn. leaves ethanol extract as hair growth.
Ziprkowski et al. Study of the toxin from the poison hairs of Thaumetopoea wilkinsoni caterpillars
Richter Die Haare
US10391050B2 (en) Dermatological, cosmetic or cosmeceutical compositions intended for skin treatment
US4883663A (en) Therapeutic powder and process of manufacturing
KR101674014B1 (en) Cosmetic composition for Preventing hair loss containing Nano emulsion of Walnuts and Chestnuts Fermented extract
EP1539201A1 (en) Antipyrotic and method of manufacturing the same
JP4197194B2 (en) Oral administration agent for intercellular adhesion suppression
DE3050070C2 (en) Cosmetic preparation
Kubo et al. Allergic contact dermatitis from Dioscorea batatas Decaisne.
DE973249C (en) Process for the production of injectable solutions from fresh placenta
DE2653595C2 (en) Process for extracting embryonic calf skin, the extract obtained in the process and its use as an active ingredient in agents for treating the skin
JP2988633B2 (en) Hair growth / hair restorer
AU2021107428A4 (en) Herbal hair oil formulation for andorgenetic alopecia: a novel process to produce a novel and effective herbal oil
JP2002114646A (en) Trichogenous and hair-growing agent
JPH11139942A (en) Hair-restoring and growing agent containing extract of morus bombycis bark and extract of mammalian placenta
DE3123943A1 (en) "HAIR TREATMENT AGENT"
DE2819131C2 (en)

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)